ECEuropean CommissionEuropean Commission to fund Life Sciences Strategy using Cohesion Fund resourcesThe European Commission last week unveiled its Life Sciences Strategy, which aims to elevate Europe’s biotechnology sector from third to first place globally by 2030, backed by an investment of €10bn. … more ➔
SandozBiomanufacturingSandoz breaks ground on US$440m biosimilar facility in SloveniaBiosimilar major Sandoz has started construction of an additional US$440m biosimilar facility near Ljubljana and it set to expand its investment footprint in Slovenia by US$1.1bn. more ➔
Unnatural Products IncPartnershipArgenx and Unnatural Products ink US$1.5bn macrocycle dealCalifornia oral macrocyclic peptide specialist Unnatural Products, Inc. and Dutch-Belgian Argenx SE have formed a multi-target research collaboration aimed at developing oral macrocyclic peptide drugs … more ➔
Vetter Pharma International GmbHCDMOVetter invests US$285m in Chicago production facilityCDMO and filled syringe specialist Vetter has broken the ground for a new clinical site construction in the greater Chicago area that is expected to be ready for early clinical filling by the end of … more ➔
HeiQ/AeoniQ, RenewcellbioeconomyAltri acquires majority stake in fibre specialist AeoniQPortuguese fibre producer Altri SGPS S.A.has signed an agreement to acquire a majority interest in Swiss clean technology company AeoniQ to support the commercial-scale development of the first fully … more ➔
adobe stock photos - Sergii Figurnyi NGTParliament halts trilogue talks on New Genomic Breeding TechniquesFinal negotiations on proposed EU regulations for plants developed through genetic precision breeding have been delayed, following opposition from a group of MEPs in the European Parliament’s ENVI … more ➔
Laverock TherapeuticsFinancingLaverock Therapeutics bags additional £6.5m seed moneyBritish targeted gene silencing specialist Laverock Therapeutics Ltd has expanded its seed funding to £20m by a new financing round led by xx and xx. The company said it will use the funds to…l more ➔
Medicines for EuropeRegulatoryEU Commissioner Várhelyi revives Biotech Act for 2025In a surprise move, Health Commissioner Oliver Várhelyi announced at the Medicines for Europe Annual Conference that the EU Biotech Act will go ahead this year, reversing its provious delay from Q3 … more ➔
www.gov.ukUpscalingUK to invest £380m in Engineering BiologyThe UK government has unveiled a new industrial strategy that includes a commitment to invest £380m in engineering biology. The package comprises an initial £196m for research and development, and … more ➔
Max Kratzer / PlectonicAI-guided drug developmentSonrai and Plectonic Biotech partner to advance cancer immunotherapiesUnder a new partnership, Plectonic Biotech will use Sonrai’s AI-powered multi-omics platform to speed up development of its Logybody cancer treatment technology. The approach aims to cut side effects … more ➔
EC
Sandoz
Unnatural Products Inc
Vetter Pharma International GmbH
HeiQ/AeoniQ, Renewcell
adobe stock photos - Sergii Figurnyi 
Laverock Therapeutics
Medicines for Europe
www.gov.uk
Max Kratzer / Plectonic